1-4 of 4
Mirjana Gotic
Close
Sort by
Journal Articles

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

Clinical Trials & Observations
Heinz Gisslinger, Mirjana Gotic, Jerzy Holowiecki, Miroslav Penka, Juergen Thiele, Hans-Michael Kvasnicka, Robert Kralovics, Petro E. Petrides
Journal: Blood
Blood (2013) 121 (10): 1720–1728.
https://doi.org/10.1182/blood-2012-07-443770
Published: 2013
Includes: Supplemental data
Journal Articles

Angiogenic Factors eNOS and VEGF Have Increased Expression in Granulocytes of JAK2V617F Homozygous Forms of Polycythemia Vera,

Vladan P Cokic, MD, PhD, Dragana Markovic, PhD, Olivera Mitrovic, MSc, Sanja Vignjevic, MSc, Dragoslava Djikic, MSc, Bojana B Beleslin-Cokic, MD, MSc, Maja Perunicic, MD, Bojana Ilic, Gordana Jovcic, PhD, Mirjana Gotic, MD, PhD, Constance Tom Noguchi, PhD, Alan N Schechter, MD
Journal: Blood
Blood (2011) 118 (21): 3847.
https://doi.org/10.1182/blood.V118.21.3847.3847
Published: 2011
Journal Articles

Final Results of the ANAHYDRET-Study: Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed WHO-Essential Thrombocythemia Patients

Heinz Gisslinger, Mirjana Gotic, Jerzy Holowiecki, Miroslav Penka, Juergen Thiele, Hans Michael Kvasnicka, Robert Kralovics, Petro E. Petrides
Journal: Blood
Blood (2008) 112 (11): 661.
https://doi.org/10.1182/blood.V112.11.661.661
Published: 2008
Journal Articles

Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed Patients with Essential Thrombocythemia: The ANAHYDRET-Study.

Heinz Gisslinger, MD, Robert Kralovics, PhD, Mirjana Gotic, MD, Jercy Holowiecki, MD, PhD, Miroslav Penka, MD, Rudolf Widmann, MD, Petro Petrides, MD
Journal: Blood
Blood (2007) 110 (11): 3547.
https://doi.org/10.1182/blood.V110.11.3547.3547
Published: 2007